The 340B Drug Pricing Program

Oversight and Investigations Subcommittee Hearing: “Oversight of 340B Drug Pricing Program”

340B Drug Pricing Program Compliance | JD Supra

340B was created to support patients, but instead, it’s being exploited to increase profits for hospitals. | PhRMA

The 340B hospital markup program is huge for hospitals, bad for you. Medicine markups are a hidden tax on patients, employers and taxpayers. Tell Congress to fix 340B. | PhRMA

Perspectives on the 340B Drug Pricing Program | The U.S. Senate Committee on Health, Education, Labor & Pensions

The federal 340B program requires drug makers to sell their products to some hospitals at a discount. Hospitals and contract pharmacies can then resell them and pocket the difference. It’s a case of the government picking winners (hospitals) and losers (drug manufacturers) among private market participants. Hospitals argue that they need the money to help patients. That is, they use the extra revenue from the program to cut costs or provide free care for those in need. But Jarrett Skorup of the

Gov. Stitt asks federal agency to revoke Planned Parenthood's drug pricing program eligibility

Taxpayers are footing the bill for the 340B Drug Pricing Program. Hospitals, contract pharmacies, and special interest sharks are profiting. They’re taking advantage of 340B discounts meant for patients, and it’s costing taxpayers. We can fix the mess if Congress reforms the program. https://www.cagw.org/340B #Fix340B | Citizens Against Government Waste | Facebook